Study suggests natural immunity is better than vaccination

Mike Campbell

June 14, 2022

A new peer-reviewed study suggests the natural immunity of an unvaccinated person offers more robust protection against re-infection than those who received the vaccine before being infected — and offers about the same level of protection as those with ‘hybrid’ immunity.

Study suggests natural immunity is superior to vaccination
Study suggests natural immunity is superior to vaccination

Accounting for more than 5.7 million people in their study, researchers Goldberg, Yair, et al. concluded in The New England Journal of Medicine that:

“…Protection was higher than that conferred after the same time had elapsed since receipt of a second dose of vaccine among previously uninfected persons.” [Emphasis added]

The researchers compared infection rates among three groups: (1) previously infected, unvaccinated; (2) previously infected, vaccinated, and (3) vaccinated persons with no previous infection. This allowed them to “assess the level of protection afforded by hybrid immunity as compared with that afforded by natural immunity or immunity conferred by vaccination.” 

The infection rate for the recovered, unvaccinated group – at 4 to 6 months after infection – is 10.5 per 100,000, which rises to 30.2 at 12 months.

Conversely, the infection rate for the uninfected, vaccinated group – from 4 to 6 months after vaccination – is 69 per 100,000. This is more than twice as high as the infection rate from group 1 in half the time.

Also, the ‘hybrid immunity’ group – meaning recovered and vaccinated – produced similar results as the unvaccinated, recovered group. Indeed, the difference is negligible at 4-6 months and 6-8 months post-infection.  

In other words, the so-called ‘hybrid protection,’ which experts said for months was ‘the best’ type of protection, looks no different than protection from natural immunity for unvaccinated persons.

With that said, waning immunity was found in all three cohorts.

This study verifies another previously covered by The Counter Signal that found that both the Pfizer and Moderna vaccines offer no long-term protection against COVID-19, particularly with the Omicron variant.

And to this point, Canada’s recent data dump reveals the boosted account for the majority of COVID deaths.

Share this story

Help Keep your News Free

Share this story

It's crucial we stay in touch

Big Tech wants to censor us, that’s why you need to stay in touch.

YOU MIGHT ALSO LIKE THESE...

Trending News

The Ontario Physicians and Surgeons Discipline tribunal (OPSDT) is currently investigating whether professional misconduct occurred by three doctors who did not follow its recommendations for Covid-19 treatment. 

Dan Fournier

December 6, 2022

Trending News

Republican senators threatened to delay funding towards National Defense until the “insane” vaccine mandate for US military members is removed. 

Mike Campbell

December 1, 2022

Trending News

Western University finally dropped its COVID 19 vaccine mandate on Tuesday, after months of petitions and protests against the institution.

TCS Wire

November 29, 2022

Trending News

Premier Danielle Smith assured Albertans that vaccine policy changes would occur, but said more time is needed to get it right. 

Mike Campbell

November 29, 2022

Trending News

Canada’s most recent COVID update shows that 80% of Canadians have yet to receive a COVID vaccine in the last six months.

Mike Campbell

November 25, 2022

Trending News

Democracy Fund lawyer Alan Honner has suggested the real reason the Trudeau Liberals invoked the Emergencies Act was because the US pressured them to do so. 

Mike Campbell

November 25, 2022

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use our website.